Ultra-fast solution for high-resolution HLA typing, featuring single-tube library preparation and sequencing using Oxford Nanopore technology.

Detailed Description

NGS-Turbo® is an innovative platform developed by GenDx for high-resolution HLA typing, specially designed for environments where speed and workflow simplicity are critical. This system combines full genomic amplification of 11 HLA loci with a single-tube library preparation procedure, followed by sequencing using nanopore technology (Oxford Nanopore Technologies).

NGS-Turbo GenDx

The system consists of three main components:

1. NGS-TurboAmp: enables simultaneous amplification of 11 HLA loci (HLA-A, -B, -C, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1, and -DPB1) using a whole-gene approach. Primers are provided pre-mixed with enzymes, buffer, and water, which simplifies the process, as it only requires adding the DNA sample. Amplification is completed in approximately 95 minutes.
2. NGS-TurboPrep: facilitates library preparation in 30 minutes without requiring DNA fragmentation, preserving the full length of the amplicons. Incubations are performed at room temperature, and the workflow can be paused at any time, providing great flexibility. The protocol is based on a streamlined sequence of steps: end prep, adapter ligation, magnetic bead cleanup, and elution.
3. Sequencing with Oxford Nanopore: the system is compatible with MinION Flow Cells (FLO-MIN114) and allows sequencing to begin immediately after sample preparation. Sequencing time can be as short as 20 minutes, depending on the device used.
NGS-Turbo Workflow

Once sequencing is complete, data is processed using NGSengine®-Turbo, GenDx’s dedicated software that analyzes results in just 5 minutes. The interface is optimized for clear visualization, minimizing the required inspection time and facilitating direct, useful reporting.

NGS-Turbo® represents a comprehensive, fast, and accurate solution for histocompatibility laboratories and transplant centers requiring results in record time without compromising quality.

NGSengine-Turbo Results

Key Features

High-resolution HLA typing in under 3 hours.
Coverage of 11 HLA loci through whole-gene amplification.
Single-tube library preparation with no fragmentation required.
Streamlined protocol with room temperature incubations.
Compatible with Oxford Nanopore sequencers (MinION Flow Cells).
Fast and reliable data analysis with NGSengine®-Turbo.
Ideal for clinical applications where speed is critical.

Ordering Information

Main components: NGS-TurboAmp, NGS-TurboPrep, MinION Flow Cell (FLO-MIN114), and NGSengine®-Turbo software. Single-tube preparation format. No fragmentation or complex intermediate steps required. Compatible with Oxford Nanopore Technologies sequencing devices. Manufacturer contact: GenDx, Utrecht (The Netherlands) – www.gendx.com

Area:

High resolution HLA typing, Immunology, Pre transplantation

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)